Spots Global Cancer Trial Database for A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Double-blind Study of KRN321 for the Treatment of Anemia in Cancer Patients
Official Title: A Double-blind, Placebo Controlled, Randomized Study of KRN321 for the Treatment of Anemia in Cancer Patients
Study ID: NCT00344409
Conditions
Interventions
Study Description
Brief Summary: To compare the effectiveness of KRN321 to placebo in the treatment of anemia in cancer patients receiving multi cycle platinum-containing chemotherapy
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Shikoku region, Ehime, , Japan
Kyusyu region, Fukuoka, Kagoshima, , Japan
Chugoku region, Hiroshima, Tottori, , Japan
Tohoku region, Iwate, Miyagi, , Japan
Kinki region, Nara, Osaka, Hyogo, , Japan
Tokai region, Shizuoka, Aichi, , Japan
Kanto region, Tokyo, Chiba, Ibaraki, Saitama, Niigata, , Japan
Contact Details
Name: Nagahiro Saijo, MD
Affiliation: National Cancer Center Hospital East
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
